Cudis vs Injective — how do they compare? Cudis trades at Rp87.66 (market cap Rp22,03M, Rp85,91M 24h volume), while Injective trades at Rp85,097 (market cap Rp8,46T, Rp1,37T 24h volume). The key difference: Injective is far larger — about 384021.8× Cudis's market cap, and Cudis's supply is capped (247,5M / 1B CUDIS (25%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Cudis for 11 Days and Injective for 36 Days on average.
| CUDIS | INJ | |
|---|---|---|
Market Cap | Rp22,03M | Rp8,46T |
Volume (24h) | Rp85,91M | Rp1,37T |
Circulating Supply | 247,5M / 1B CUDIS (25%) | 100M INJ |
Typical Hold Time | 11 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Cudis is trading at Rp87.293 with a market cap of Rp21.8M, showing a bearish technical outlook as moving averages signal strong selling pressure and oscillators remain neutral. The asset is near resistance at Rp86 with support at Rp80, while RSI_6 at 13.35 indicates potential oversold conditions. No recent protocol updates or ecosystem developments have been noted, and the token's circulating supply is 247.5M out of a 1B max supply, with a 25% circulation rate.
Overall, the outlook is cautious due to bearish signals and low liquidity, but the oversold RSI may present a short-term opportunity. Major risks include high volatility, limited exchange depth, and regulatory uncertainty in crypto markets. Investors should monitor for any network activity shifts or exchange listings that could impact price dynamics.
Injective (INJ) is trading at Rp86,314 with a market cap of Rp8.6T, showing bullish technical signals from moving averages while oscillators remain neutral. The token is currently positioned between key support at Rp86,075 and resistance at Rp89,928, with an average hold time of 36 days indicating moderate investor patience. Recent technical momentum suggests potential upward movement if it can break through the immediate resistance level.
Overall outlook remains cautiously optimistic with technical strength supporting potential gains, though the neutral oscillator readings suggest consolidation may precede further movement. Key opportunities include the bullish moving average alignment and strong support levels, while risks involve typical crypto volatility and the need for sustained volume to confirm the bullish trend.
What Pluang investors did over the last 30 days
Latest headlines on both assets
CUDIS is creating the first-ever Longevity Protocol aimed at making longevity trackable, personalized, and rewarding. By integrating the CUDIS Ring, an AI-powered Longevity Hub, and a blockchain-driven Super App, users will have complete ownership of their health data, receive real-time insights on their longevity, and gain economic incentives for optimizing their biological health. CUDIS is building a new ecosystem for longevity that includes realistic and effective products, programs, and services, in collaboration with partners around the world.
Read more on CUDIS →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →